Related Experiment Video

Updated: Aug 23, 2025

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

6.4K

Small-molecule compound SYG-180-2-2 attenuates Staphylococcus aureus virulence by inhibiting hemolysin and

Lulin Rao1, Yanlei Xu1, Li Shen1

  • 1Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.

Frontiers in Cellular and Infection Microbiology
|October 31, 2022
PubMed

Insights

SYG-180-2-2, a novel compound, effectively reduces Staphylococcus aureus virulence by inhibiting hemolytic activity and staphyloxanthin synthesis, without direct antibacterial effects. This virulence factor therapy shows promise against drug-resistant infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Multi-drug resistant Staphylococcus aureus infections pose a significant global health threat.
  • Developing novel antibacterial agents targeting virulence factors is crucial to combat resistance.
  • SYG-180-2-2 is a previously synthesized small molecule compound with anti-biofilm activity.

Purpose of the Study:

  • To investigate the anti-virulence efficacy of SYG-180-2-2 against Staphylococcus aureus.
  • To evaluate the compound's impact on key virulence factors and gene expression.

Main Methods:

  • Minimum Inhibitory Concentration (MIC) and growth curve assays to assess antibacterial activity.
  • Assays for hemolytic activity, staphyloxanthin synthesis, and oxidant/blood sensitivity.
  • Quantitative Polymerase Chain Reaction (qPCR) for gene expression analysis (hlb, crtM, crtN, sigB, sodA, sodM, katA).
  • Galleria Mellonella larvae assay and mouse skin abscess model for in vivo efficacy.

Main Results:

  • SYG-180-2-2 exhibited no direct antibacterial activity or lethality against S. aureus.
  • The compound significantly inhibited hemolytic activity and staphyloxanthin synthesis, increasing susceptibility to oxidants and human whole blood.
  • SYG-180-2-2 downregulated genes involved in hemolysis (hlb), staphyloxanthin synthesis (crtM, crtN, sigB), and oxidative stress (sodA, sodM, katA).
  • In vivo studies showed reduced bacterial virulence in Galleria Mellonella larvae and decreased skin abscess formation in mice.

Conclusions:

  • SYG-180-2-2 is a promising anti-virulence agent for Staphylococcus aureus.
  • It attenuates virulence by targeting genes responsible for hemolytic activity and staphyloxanthin production.
  • This compound offers a potential therapeutic strategy against drug-resistant S. aureus infections.
Keywords:
SYG-180-2-2Staphylococcus aureushemolysinstaphyloxanthinvirulence

More Related Videos

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues07:10

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues

Published on: February 19, 2019

9.1K
Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

2.9K

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
73
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.5K